NASDAQ:AXLA Axcella Health Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Axcella Health Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.78 +0.05 (+1.06 %) (As of 09/17/2020 12:00 AM ET) Add Compare Share Today's Range$4.63Now: $4.78▼$4.8550-Day Range$4.20MA: $5.01▼$5.9152-Week Range$2.25Now: $4.78▼$7.73Volume102,731 shsAverage Volume200,104 shsMarket Capitalization$174.03 millionP/E RatioN/ADividend YieldN/ABeta1.21 ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesShort InterestSocial Media There is no company description available for Axcella Health Inc.Read More Beat the Market (BTM) Rank™ 4.5 Analyst's Opinion Consensus RatingAxcella Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $15.80, Axcella Health has a forecasted upside of 230.9% from its current price of $4.78.Amount of Analyst CoverageAxcella Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.7 Community Rank Outperform VotesAxcella Health has received 51 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAxcella Health has received 44 “underperform” votes. (Add your “underperform” vote.)Community SentimentAxcella Health has received 53.68% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Axcella Health and other stocks. Vote “Outperform” if you believe AXLA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AXLA will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAxcella Health does not currently pay a dividend.Dividend GrowthAxcella Health does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Axcella Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 10.40% of the stock of Axcella Health is held by insiders.Percentage Held by Institutions68.53% of the stock of Axcella Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Axcella Health are expected to decrease in the coming year, from ($0.97) to ($2.39) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Axcella Health is -1.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Axcella Health is -1.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAxcella Health has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 4.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.64 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AXLA Previous Symbol CUSIPN/A CIKN/A Webwww.axcellahealth.com Phone857-320-2200Debt Debt-to-Equity Ratio0.21 Current Ratio11.31 Quick Ratio11.31Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.61 per share Price / Book1.83Profitability EPS (Most Recent Fiscal Year)($3.55) Net Income$-59,040,000.00 Net MarginsN/A Return on Equity-90.28% Return on Assets-61.05%Miscellaneous EmployeesN/A Outstanding Shares36,447,000Market Cap$174.03 million Next Earnings Date11/10/2020 (Estimated) OptionableNot Optionable $4.78 +0.05 (+1.06 %) (As of 09/17/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive AXLA News and Ratings via Email Sign-up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter. Axcella Health (NASDAQ:AXLA) Frequently Asked Questions How has Axcella Health's stock been impacted by COVID-19 (Coronavirus)? Axcella Health's stock was trading at $3.32 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AXLA shares have increased by 43.8% and is now trading at $4.7750. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Axcella Health? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Axcella Health. When is Axcella Health's next earnings date? Axcella Health is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for Axcella Health. How were Axcella Health's earnings last quarter? Axcella Health Inc (NASDAQ:AXLA) posted its earnings results on Wednesday, August, 5th. The company reported ($0.48) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.56) by $0.08. View Axcella Health's earnings history. What price target have analysts set for AXLA? 5 equities research analysts have issued 12-month target prices for Axcella Health's shares. Their forecasts range from $9.00 to $25.00. On average, they anticipate Axcella Health's share price to reach $15.80 in the next year. This suggests a possible upside of 230.9% from the stock's current price. View analysts' price targets for Axcella Health. Are investors shorting Axcella Health? Axcella Health saw a decline in short interest in August. As of August 14th, there was short interest totaling 269,700 shares, a decline of 36.7% from the July 30th total of 425,900 shares. Based on an average daily volume of 322,400 shares, the short-interest ratio is currently 0.8 days. Currently, 2.0% of the company's stock are sold short. View Axcella Health's Short Interest. Who are some of Axcella Health's key competitors? Some companies that are related to Axcella Health include Checkmate Pharmaceuticals (INBX), Osiris Therapeutics (OSIR), Tcr2 Therapeutics (TCRR), Autolus Therapeutics (AUTL), Avrobio (AVRO), Poseida Therapeutics (PSTX), Oyster Point Pharma (OYST), Allovir (ALVR), Aerie Pharmaceuticals (AERI), Scholar Rock (SRRK), Fusion Pharmaceuticals (FUSN), Aptose Biosciences (APTO), Orchard Therapeutics (ORTX), CEL-SCI (CVM) and MeiraGTx (MGTX). View all competitors. What other stocks do shareholders of Axcella Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Sorrento Therapeutics (SRNE), NVIDIA (NVDA), Occidental Petroleum (OXY), VBI Vaccines (VBIV), Coty (COTY), Energy Transfer LP Unit (ET), Evofem Biosciences (EVFM), Main Street Capital (MAIN), Myovant Sciences (MYOV) and Pfizer (PFE). When did Axcella Health IPO? (AXLA) raised $76 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO. What is Axcella Health's stock symbol? Axcella Health trades on the NASDAQ under the ticker symbol "AXLA." Who are Axcella Health's major shareholders? Axcella Health's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Flagship Pioneering Inc. (34.43%), FMR LLC (14.75%), Artal Group S.A. (2.47%), Monashee Investment Management LLC (0.62%), Marshall Wace LLP (0.33%) and EAM Investors LLC (0.25%). Company insiders that own Axcella Health stock include Catherine A Sohn, D Clay Bretches, David R Epstein, Laurent Chardonnet and Ventures Fund Iv LP Flagship. View institutional ownership trends for Axcella Health. Which institutional investors are buying Axcella Health stock? AXLA stock was purchased by a variety of institutional investors in the last quarter, including Flagship Pioneering Inc., FMR LLC, Artal Group S.A., Monashee Investment Management LLC, Marshall Wace LLP, EAM Investors LLC, Jacobs Levy Equity Management Inc., and Nuveen Asset Management LLC. Company insiders that have bought Axcella Health stock in the last two years include Catherine A Sohn, D Clay Bretches, David R Epstein, Laurent Chardonnet, and Ventures Fund Iv LP Flagship. View insider buying and selling activity for Axcella Health. How do I buy shares of Axcella Health? Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Axcella Health's stock price today? One share of AXLA stock can currently be purchased for approximately $4.78. How big of a company is Axcella Health? Axcella Health has a market capitalization of $174.03 million. The company earns $-59,040,000.00 in net income (profit) each year or ($3.55) on an earnings per share basis. What is Axcella Health's official website? The official website for Axcella Health is www.axcellahealth.com. How can I contact Axcella Health? Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200. This page was last updated on 9/18/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
